The Guest Editors have focused on methods of diagnosing and
evaluating IBD to help guide optimal treatment to maximize clinical
outcomes and minimize risks. Authors have provided state-of-the-art
updates with practical information/guidelines/algorithms and
cutting-edge data for incorporation into practice. The first set of
articles deals with endoscopy: its role in diagnosis and monitoring
IBD; the growing importance of chromoendoscopy in IBD surveillance
exams; assessment of post-operative recurrence; and finally the
emerging role of capsule endoscopy. The second section focuses on
specific scenarios that IBD physicians encounter frequently: health
maintenance in IBD focusing on proper vaccinations; the growing
problem of Clostridium difficile in IBD; assessment of pouch
problems; optimal evaluation of perianal disease; the state of the
art in using thiopurines including use of allopurinol to optimize
metabolites and optimizing the use of infliximab by measuring
levels and antibodies to infliximab; factors to consider in
choosing monotherapy versus combination therapy and communication
of risk/benefit to patients; and finally disability assessment in
IBD. The third and final section highlights noninvasive methods to
evaluate IBD: clinical predictors of aggressive or disabling
disease; the evolving role of specific antibodies in diagnosing,
subtyping and most recently prognosticating in IBD; stool markers
(calproctectin and lactoferrin) for evaluating and monitoring IBD;
the growing role of imaging modalities with emphasis on MR
enterography and CT enterography; and finally, the genetics of IBD
and the potential role of genetic testing in the
diagnosis/prognosis and tailoring of therapy.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!